Cresco Labs: Canaccord Lowers Price Target To $19

Cresco Labs (CSE: CL) reported its first-quarter financial results this past week. The company announced revenue of $178.4 million, a 9.9% increase quarter over quarter. Gross profit margin came in at 48.8%, and the company experienced record revenue in both its wholesale and retail segments. The company did come out with some sort of soft guidance, saying that they will have an annualized run rate of over $1 billion by the end of 2021 and gross profit margin will be above 50%.

Two out of 16 analysts lowered their 12-month price target on Cresco Labs, bringing the average 12-month price target down to C$22.74 from C$23.36 prior. The company has 16 analysts covering the stock with four of them having strong buy ratings, 11 have buy ratings and one analyst has a hold rating. The street high comes from Stifel-GMP with a C$34 price target, and the lowest target comes from Echelon Wealth with an C$18 price target.

In Canaccord’s note, their analyst Derek Dley reiterated his speculative buy rating but lowered their 12-month price target to C$19 from C$22,writing, “In our view, Cresco is well-positioned to capitalize on the increasing acceptance of cannabis within its core states.”

For the results, revenue beat Canaccord’s estimates of $173 million but came in shy on their EBITDA estimate of $41 million. The revenue beat mainly came from both wholesale and retail increasing consecutively. Net wholesale revenues rose 6% while retail rose 15%, slightly shifting the mix to a wholesale/retail revenue split of 54%/46%.

For the outlook, Dley says that the slowed-down opening of new dispensaries in Illinois hit Cresco’s wholesale revenue, but with 18 stores opened in March/April that should provide a solid tailwind for the top line.

Below you can see Canaccord’s updated 2021/2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Gold/Silver: People Can Still Lose Money In This Bull Market!? | Rick Rule

He Said $300 Silver!? | Peter Krauth

Dollar Will Collapse, Gold and Silver Are the Only Safe Havens | Jim Rogers

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Take-Two: BMO Cuts Target, Foresees Weakness In Microtransactions

On September 1st, BMO Capital Markets reiterated their outperform rating on Take-Two Interactive Software, Inc....

Saturday, September 3, 2022, 01:07:00 PM

Cronos Group: Canaccord Lowers Price Target To $7 Following Poor Results

Last week, Cronos Group (TSX: CRON) reported its second quarter financial results. The company generated...

Thursday, August 12, 2021, 02:07:00 PM

Valens: Second Quarter Consensus Estimates

The Valens Company (TSX: VLNS) announced that they will be reporting their second quarter financials...

Tuesday, July 13, 2021, 02:30:00 PM

Karora: Haywood Reiterates Ratings After Three Year Guidance Announcement

On June 28th, Karora Resources Inc. (TSX: KRR) announced its three-year production guidance, whereby they...

Wednesday, June 30, 2021, 04:53:00 PM

Cresco Labs Posts $214.4 Million In Revenue, $23.7 Million Net Loss In Q1 2022

Cresco Labs (CSE: CL) released its Q1 2022 financials, highlighting a quarterly revenue of $214.4 million....

Wednesday, May 18, 2022, 11:28:00 AM